Skip to main content
Thursday, July 25, 2024 - 2:56pm
QuantumScape HQ

QuantumScape reported 2024 fiscal year second quarter earnings after the market closed on Wednesday.

Read more
News, Top Stories, Movers, Tech
Thursday, July 25, 2024 - 2:53pm
ChargePoint

ChargePoint shares surge as the company expands to over one million EV charging stations, facilitating over 10 billion electric miles, amidst rising demand in the EV market.

Read more
Thursday, July 25, 2024 - 2:36pm
Benzinga Briefs

Edwards Lifesciences reported Q2 results, sales increased 7% to $1.632B, TAVR sales grew 5%, company to acquire JenaValve and Endotronix, lowers TAVR guidance.

Read more
Thursday, July 25, 2024 - 2:34pm
Uber.Lyft_.Shutterstock

Shares of Uber Technologies, Inc. (NYSE: UBER) and Lyft, Inc. (NASDAQ: LYFT) are volatile Thursday following a significant court ruling allowing the ride-share companies to treat drivers as contractors.

Read more
News, Movers
Thursday, July 25, 2024 - 2:34pm
Oracle stock

Oracle reportedly entered a deal with Rai Way to implement AI systems at data centers. Also inked managed services agreement with Salam for digital transformation.

Read more
Thursday, July 25, 2024 - 2:22pm
Marvell Technologies

Marvell Technology shares are trading higher Thursday after the company announced the Teralynx 10 Ethernet switch device is in volume production with customer deployments underway. Here's what to know:

Read more
News, Top Stories, Movers, Tech
Thursday, July 25, 2024 - 2:18pm
Blink Charger

Blink Charging sees stock rise as it secures NASPO ValuePoint contract, expanding EV charging solutions for public entities nationwide.

Read more
Thursday, July 25, 2024 - 2:00pm
Business,Man,Sign,A,Contract,Investment,Professional,Document,Agreement.,Meeting

Helmerich & Payne acquires KCA Deutag for $1.9725 billion, expanding its Middle East operations and boosting cash flow.

Read more
Equities, M&A, Mid Cap, News, Movers
Thursday, July 25, 2024 - 1:53pm
CMMB

Chemomab Therapeutics reports successful Phase 2 SPRING trial results for CM-101 in primary sclerosing cholangitis, showing safety and efficacy. Key findings include significant improvements in liver stiffness and pruritis, with a favorable safety profile.

Read more